1616851-91-2

Upstream product

• 42558-54-3 Methyl 4-methyl-3-oxopentanoate 
• 65596-31-8 methyl 3-hydroxy-4-methylpentanoate 
• 1616855-04-9 methyl 4-methyl-3-(methylsulfonyloxy)pentanoate 
• 1616855-06-1 1-hydroxy-4-methylpentan-3-yl methanesulfonate 
• 1616854-57-9 tert-butyl 4-(2-(1-methoxy-1-oxopropan-2-yl)phenylamino)piperidine-1-carboxylate 
• 1616855-08-3 3-(2-chloro-5-methoxyphenoxy)-4-methylpentan-1-ol 
• 478613-43-3 3-(2-chloro-5-methoxyphenoxy)-4-methylpentyl methanesulfonate 
• 1616855-11-8 tert-butyl 4-(3-methyl-3-(2-(methylamino)-2-oxoethyl)-2-oxoindolin-1-yl)piperidine-1-carboxylate 
• 1616851-89-8 2-(1-(1-(3-(2-chloro-5-methoxyphenoxy)-4-methylpentyl)piperidin-4-yl)-3-methyl-2-oxoindolin-3-yl)-N-methylacetamide 
• 1358667-69-2 tert-butyl 4-(3-methyl-2-oxoindolin-1-yl)piperidine-1-carboxylate 
• 1616854-60-4 tert-butyl 4-(3-(2-methoxy-2-oxoethyl)-3-methyl-2-oxoindolin-1-yl)piperidine-1-carboxylate 
• 30095-98-8 methyl (2-nitrophenyl)acetate 
• 3740-52-1 2-(2-nitrophenyl)acetic acid 
• 30096-07-2 methyl α-methyl-2-nitrobenzeneacetate 

Relevant academic research and scientific papers

HETEROCYCLIC COMPOUNDS AND METHODS OF USE THEREOF

Provided herein are heterocyclyl compounds, methods of their synthesis, pharmaceutical compositions comprising the compounds, and methods of their use. The compounds provided herein are useful for the treatment, prevention, and/or management of various neurological disorders, including but not limited to, psychosis and schizophrenia.